These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15526495)

  • 1. Hypertension in obese patients: a dysmetabolic hypertension with a possible adipocyte dysfunction mechanism.
    Blaj S; Stanciu S; Jurcut C; Ciobîcă L
    Rom J Intern Med; 2003; 41(2):103-11. PubMed ID: 15526495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans.
    Sarzani R; Salvi F; Dessì-Fulgheri P; Rappelli A
    J Hypertens; 2008 May; 26(5):831-43. PubMed ID: 18398321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of hypertension in the cardiometabolic syndrome.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
    J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome.
    Correia ML; Rahmouni K
    Diabetes Obes Metab; 2006 Nov; 8(6):603-10. PubMed ID: 17026484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension as part of the metabolic syndrome.
    Cheung B
    J Hum Hypertens; 2008 Dec; 22(12):871-4. PubMed ID: 18548089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension, obesity, and the renin-angiotensin system: a tale of tight associations.
    Sibley S
    Minn Med; 2003 Jan; 86(1):46-8. PubMed ID: 12585560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-mediated upregulation of the renin angiotensin system in human subcutaneous adipocytes is reduced by rosiglitazone.
    Harte A; McTernan P; Chetty R; Coppack S; Katz J; Smith S; Kumar S
    Circulation; 2005 Apr; 111(15):1954-61. PubMed ID: 15837949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of aldosterone with obesity-related hypertension and the metabolic syndrome.
    Vogt B; Bochud M; Burnier M
    Semin Nephrol; 2007 Sep; 27(5):529-37. PubMed ID: 17868790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms for vascular injury in the metabolic syndrome.
    Yamagishi S; Nakamura K; Jinnouchi Y; Takenaka K; Imaizumi T
    Drugs Exp Clin Res; 2005; 31(3):123-9. PubMed ID: 16033251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of renin-angiotensin system in diabetes mellitus with hypertension].
    Itoh H
    Nihon Rinsho; 2003 Jul; 61(7):1145-53. PubMed ID: 12877076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.
    Jonk AM; Houben AJ; de Jongh RT; Serné EH; Schaper NC; Stehouwer CD
    Physiology (Bethesda); 2007 Aug; 22():252-60. PubMed ID: 17699878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoid receptor activation in obesity hypertension.
    Nagase M; Fujita T
    Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineralocorticoid-stimulating activity of adipose tissue.
    Lamounier-Zepter V; Ehrhart-Bornstein M; Bornstein SR
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):567-75. PubMed ID: 16311217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity, metabolic syndrome, adipocytes and vascular function: A holistic viewpoint.
    Achike FI; To NH; Wang H; Kwan CY
    Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):1-10. PubMed ID: 21083697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of adipose tissue for cardiovascular-renal regulation in health and disease.
    Engeli S; Sharma AM
    Horm Metab Res; 2000; 32(11-12):485-99. PubMed ID: 11246814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heart in obesity-hypertension.
    Morse SA; Bravo PE; Morse MC; Reisin E
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):647-58. PubMed ID: 16076275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural equation modeling of sleep apnea, inflammation, and metabolic dysfunction in children.
    Waters KA; Mast BT; Vella S; de la Eva R; O'Brien LM; Bailey S; Tam CS; Wong M; Baur LA
    J Sleep Res; 2007 Dec; 16(4):388-95. PubMed ID: 18036084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipocytokines: fat-derived humoral mediators of metabolic homeostasis.
    Staiger H; Häring HU
    Exp Clin Endocrinol Diabetes; 2005 Feb; 113(2):67-79. PubMed ID: 15772897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.